Office of the Director; Notice of Charter Renewal, 67949 [2019-26709]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 239 / Thursday, December 12, 2019 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: January 16, 2020.
Closed: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Open: 12:00 p.m. to 5:00 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences,
National Institutes of Health, One Democracy
Plaza, Room 1072, Bethesda, MD 20892, 301–
435–0809, anna.ramseyewing@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 6, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–26710 Filed 12–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Center for Advancing
Translational Sciences; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Cures Acceleration
Network Review Board.
The meeting will be open to the
public as indicated below, viewing
virtually by WebEx. Individuals can
register to view and access the meeting
by the link below.
https://nih.webex.com/nih/onstage/
g.php?MTID=e56b929e2a7d82a92a
5e58e040d7d103d
VerDate Sep<11>2014
17:56 Dec 11, 2019
Jkt 250001
1. Go to ‘‘Event Status’’ on the lefthand side of page, then click ‘‘Register’’.
On the registration form, enter your
information and then click ‘‘Submit’’ to
complete the required registration.
2. You will receive a personalized
email with the live event link.
Name of Committee: Cures Acceleration
Network Review Board.
Date: January 16, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Anna L. Ramsey-Ewing,
Ph.D., Executive Secretary, National Center
for Advancing Translational Sciences,
National Institutes of Health, One Democracy
Plaza, Room 1072, Bethesda, MD 20892, 301–
435–0809 anna.ramseyewing@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 6, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–26711 Filed 12–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter
Renewal
It is determined that the Advisory
Committee to the Deputy Director for
Intramural Research, National Institutes
of Health, is in the public interest in
connection with the performance of
duties imposed on the National
Institutes of Health by law, and that
these duties can best be performed
through the advice and counsel of this
group.
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the Advisory
Committee to the Deputy Director for
Intramural Research, National Institutes
of Health, was renewed for an
additional two-year period on August
15, 2019.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
67949
(Mail code 4875), Telephone (301) 496–
2123, or harriscl@od.nih.gov.
Dated: December 6, 2019.
Natasha M. Copeland,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–26709 Filed 12–11–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0063]
Agency Information Collection
Activities: Petroleum Refineries in
Foreign Trade Sub-Zones
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 30-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
DATES: Comments are encouraged and
must be submitted (no later than
January 13, 2020) to be assured of
consideration.
SUMMARY:
Interested persons are
invited to submit written comments on
this proposed information collection to
the Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to the OMB Desk Officer for Customs
and Border Protection, Department of
Homeland Security, and sent via
electronic mail to dhsdeskofficer@
omb.eop.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Requests for additional PRA information
should be directed to Seth Renkema,
Chief, Economic Impact Analysis
Branch, U.S. Customs and Border
Protection, Office of Trade, Regulations
and Rulings, 90 K Street NE, 10th Floor,
Washington, DC 20229–1177,
Telephone number 202–325–0056 or via
email CBP_PRA@cbp.dhs.gov. Please
note that the contact information
provided here is solely for questions
regarding this notice. Individuals
seeking information about other CBP
E:\FR\FM\12DEN1.SGM
12DEN1
]]>Agencies
[Federal Register Volume 84, Number 239 (Thursday, December 12, 2019)]
[Notices]
[Page 67949]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26709]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter Renewal
It is determined that the Advisory Committee to the Deputy Director
for Intramural Research, National Institutes of Health, is in the
public interest in connection with the performance of duties imposed on
the National Institutes of Health by law, and that these duties can
best be performed through the advice and counsel of this group.
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the Advisory Committee to the Deputy Director for
Intramural Research, National Institutes of Health, was renewed for an
additional two-year period on August 15, 2019.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: December 6, 2019.
Natasha M. Copeland,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-26709 Filed 12-11-19; 8:45 am]
BILLING CODE 4140-01-P
